Carboplatin ± Nivolumab in Metastatic TNBC Trial
In a groundbreaking advancement that could reshape the therapeutic landscape for metastatic triple-negative breast cancer (mTNBC), researchers have conducted a ...
In a groundbreaking advancement that could reshape the therapeutic landscape for metastatic triple-negative breast cancer (mTNBC), researchers have conducted a ...
In a remarkable stride toward advancing cancer immunotherapy, a recent phase II clinical trial has illuminated the promising synergy between ...
In the relentless quest to conquer breast cancer, researchers at the Sylvester Comprehensive Cancer Center, part of the University of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine